ArticlePrenatal diagnosis2025
The Value of Enhancing Sonographic Phenotyping to Improve the Diagnostic Yield of Noninvasive Prenatal Diagnosis (NIPD) for Achondroplasia.
Article in Prenatal diagnosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesAchondroplasia is the most common form of skeletal dysplasia and is usually suspected in the third trimester of pregnancy based on abnormal sonographic findings. Non-invasive prenatal diagnosis (NIPD), based on the detection of pathogenic FGFR3 variants in maternal plasma, provides an accurate genetic confirmation. The aim of this study was to identify the sonographic markers most strongly associated with achondroplasia, with the intention of enhancing the specificity of NIPD referrals and improving diagnostic efficiency, thereby supporting clinicians in their diagnostic approach.
methodsA retrospective cohort study was conducted on 275 NIPD tests performed in the laboratory between 2017 and 2023. Of these, 176 were requested due to sonographic abnormalities suggestive of achondroplasia. Sonographic reports were systematically reviewed to identify key ultrasound features correlated with a positive NIPD result.
resultsAmong the NIPD tests ordered due to sonographic anomalies, 34.1% were confirmed positive for achondroplasia. Abnormal proximal end of the femur, frontal bossing, and a pronounced nasal saddle were the most specific markers, achieving a diagnostic yield of 87.5% when all three features were present. In contrast, short femur length alone had a poor diagnostic yield (8.9%).
conclusionTargeted sonographic phenotyping significantly improves the diagnostic yield of NIPD for achondroplasia. These findings support the need for more refined prenatal screening guidelines to enhance test specificity and optimise patient care as new achondroplasia treatments emerge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.